Literature DB >> 10445089

[Prognostic factors in the surgical management of acromegaly].

C Salaun1, L Foubert, M Vialatou, M Kujas, G Turpin.   

Abstract

To determine the prognostic factors of surgical cure of growth hormone secreting pituitary adenomas, we have studied 48 patients operated between 1982 and 1992. We compared the features of the cured group (n = 18) with the non cured group (n = 30). We found that the factors of poor prognostic were: young age, growth hormone level before surgery over 50 ng/ml, invasive adenomas, monohormonal status in immunocytochemistry, and lack of decrease in postoperative growth hormone level during the glucose tolerance test.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10445089

Source DB:  PubMed          Journal:  Ann Med Interne (Paris)        ISSN: 0003-410X


  6 in total

Review 1.  Update on prognostic factors in acromegaly: Is a risk score possible?

Authors:  E Fernandez-Rodriguez; F F Casanueva; I Bernabeu
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

Review 2.  Clinical implications of growth hormone-secreting tumor subtypes.

Authors:  Katja Kiseljak-Vassiliades; Shibana Shafi; Janice M Kerr; Tzu L Phang; B K Kleinschmidt-DeMasters; Margaret E Wierman
Journal:  Endocrine       Date:  2012-03-21       Impact factor: 3.633

Review 3.  Management of aggressive growth hormone secreting pituitary adenomas.

Authors:  Daniel A Donoho; Namrata Bose; Gabriel Zada; John D Carmichael
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

4.  Surgery and radiosurgery for acromegaly: a review of indications, operative techniques, outcomes, and complications.

Authors:  Yvette Marquez; Alexander Tuchman; Gabriel Zada
Journal:  Int J Endocrinol       Date:  2012-03-01       Impact factor: 3.257

5.  Efficacy and complications of neurosurgical treatment of acromegaly.

Authors:  Anna Krzentowska-Korek; Filip Gołkowski; Agata Bałdys-Waligórska; Alicja Hubalewska-Dydejczyk
Journal:  Pituitary       Date:  2011-06       Impact factor: 4.107

6.  A consensus on the diagnosis and treatment of acromegaly complications.

Authors:  S Melmed; F F Casanueva; A Klibanski; M D Bronstein; P Chanson; S W Lamberts; C J Strasburger; J A H Wass; A Giustina
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.